Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis

  Free Subscription

12.02.2024

1 Am J Gastroenterol
1 BMC Gastroenterol
1 BMC Pediatr
2 Eur J Gastroenterol Hepatol
1 Gastroenterology
3 J Hepatol
1 J Infect Dis
1 J Med Virol
3 J Viral Hepat
1 J Virol
1 Pediatr Infect Dis J
1 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A



    Am J Gastroenterol

  1. BUI H, Kumar NG, Singal AG, Boparai J, et al
    Implementation of a hepatocellular carcinoma surveillance program in a community-based integrated health system in patients with hepatitis C cirrhosis.
    Am J Gastroenterol. 2024 Feb 9. doi: 10.14309/ajg.0000000000002704.
    >> Share


    BMC Gastroenterol

  2. KUROKAWA S, Kobori T, Yoneda M, Ogawa Y, et al
    Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma.
    BMC Gastroenterol. 2024;24:57.
    >> Share


    BMC Pediatr

  3. ALTAMIMI E, Al Omari D, Obeidat H, Barham K, et al
    Retrospective, single-center analysis of autoimmune hepatitis in Jordanian children: clinical features, treatments, and outcomes.
    BMC Pediatr. 2024;24:102.
    >> Share


    Eur J Gastroenterol Hepatol

  4. LAI X, Chen H, Dong X, Zhou G, et al
    AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV infection.
    Eur J Gastroenterol Hepatol. 2024;36:338-344.
    >> Share

  5. ARYAN M, Qian S, Chen Z, Louissaint J, et al
    Patients with early-stage alcohol-associated liver disease are at increased risk of hospital readmission and death.
    Eur J Gastroenterol Hepatol. 2024;36:318-325.
    >> Share


    Gastroenterology

  6. HERMS Q, Fuster-Anglada C, Juanola A
    Pembrolizumab-induced Liver Injury: Beyond Immune-Mediated Hepatitis.
    Gastroenterology. 2024 Feb 4:S0016-5085(24)00133.
    >> Share


    J Hepatol

  7. LIU C, Guo C, Liu K
    Changes of hepatic myeloid cells in chronic viral hepatitis and after cure and their clinical significance.
    J Hepatol. 2024 Feb 6:S0168-8278(24)00121-1. doi: 10.1016/j.jhep.2024.
    >> Share

  8. HIRSCHFIELD GM, Lohse AW
    Editorial: Treating Autoimmune Hepatitis - more science, more progress, better therapy.
    J Hepatol. 2024 Feb 1:S0168-8278(24)00098-9. doi: 10.1016/j.jhep.2024.
    >> Share

  9. ALKASHASH A, Zhang X, Vuppalanchi R, Lammert C, et al
    Distinction of Autoimmune Hepatitis from Drug Induced Autoimmune Like Hepatitis: The Answer Lies at the Interface.
    J Hepatol. 2024 Feb 1:S0168-8278(24)00100-4. doi: 10.1016/j.jhep.2024.
    >> Share


    J Infect Dis

  10. MUSONDA T, Wallace MS, Patel H, Martin OP, et al
    New window into hepatitis B in Africa: Liver sampling combined with single cell omics enables deep and longitudinal assessment of intrahepatic immunity in Zambia.
    J Infect Dis. 2024 Feb 9:jiae054. doi: 10.1093.
    >> Share


    J Med Virol

  11. LIU W, Li L, Yin M, Cao C, et al
    High-speed centrifugation rather than Lipoclear reagent can be used for removing the interference of lipemia on serological tests of infectious diseases: AIDS, hepatitis B, hepatitis C, and syphilis by chemiluminescent microparticle immunoassay.
    J Med Virol. 2024;96:e29385.
    >> Share


    J Viral Hepat

  12. WU L, Yang Z, Zheng M
    Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy.
    J Viral Hepat. 2024 Feb 8. doi: 10.1111/jvh.13926.
    >> Share

  13. EPSTEIN RL, Buzzee B, White LF, Feld JJ, et al
    Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virus.
    J Viral Hepat. 2024 Feb 7. doi: 10.1111/jvh.13925.
    >> Share

  14. LV R, Lu Y, Xiang W, Meng M, et al
    Chronic viral hepatitis C micro-elimination program using telemedicine in Guigang city.
    J Viral Hepat. 2024 Feb 7. doi: 10.1111/jvh.13922.
    >> Share


    J Virol

  15. FRERICKS N, Brown RJP, Reinecke BM, Herrmann M, et al
    Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.
    J Virol. 2024 Feb 6:e0192123. doi: 10.1128/jvi.01921.
    >> Share


    Pediatr Infect Dis J

  16. MALIK F, Crichton S, Plotnikova Y, Latysheva I, et al
    Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe.
    Pediatr Infect Dis J. 2024 Feb 2. doi: 10.1097/INF.0000000000004271.
    >> Share


    PLoS One

  17. KENFACK-MOMO R, Ngounoue MD, Kenmoe S, Takuissu GR, et al
    Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0284169.
    >> Share


    PLoS Pathog

  18. BENDER D, Koulouri A, Wen X, Glitscher M, et al
    Guanylate-binding protein 1 acts as a pro-viral factor for the life cycle of hepatitis C virus.
    PLoS Pathog. 2024;20:e1011976.
    >> Share


    Proc Natl Acad Sci U S A

  19. CAO QM, Boonchuen P, Chen TC, Lei S, et al
    Virus-derived circular RNAs populate hepatitis C virus-infected cells.
    Proc Natl Acad Sci U S A. 2024;121:e2313002121.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016